The Ideal Venous Stent and Early Results from Venous Stent Trials PNEC, Seattle
|
|
- Clarissa Ginger Briggs
- 5 years ago
- Views:
Transcription
1 The Ideal Venous Stent and Early Results from Venous Stent Trials 2017 PNEC, Seattle Bill Marston MD Professor, Div of Vascular Surgery University of N. Carolina
2 DISCLOSURES William Marston, MD Consultant/Advisory Board: Veniti, Cardinal Healthcare, Tactile Medical, Factor Therapeutics, Volcano Inc Stock: Veniti Inc
3 982 iliac lesions treated Characteristics Median age 54 Female:male 2.6:1 CEAP clinical class 2 7% 3 47% 4 24% 5 5% 6 17% J Vasc Surg 2007;46:979
4 Long-term outcomes: Iliac stent patency Median follow-up time 22 months Acute thrombosis 1.5% Iliac vein patency at 72 months 67% primary 89% assisted primary 93% secondary J Vasc Surg 2007;46:979
5 Failure modes of current stents
6 Wallstent: Designed for biliary Inadequate strength at stent ends Migration Imprecise placement leading to need for additional stent or obstruction of contralateral side Fibrous scarring/restenosis Difficulty determining distal end of stent
7 Desirable characteristics for a Flexibility Expansile strength Venous Stent Minimal shortening on deployment for accuracy Resistance to hyperplastic ingrowth Long lengths to reduce need for multiple stents 7
8 Novel venous stents: Design characteristics Veniti stent Nitinol self expanding Closed cell design Increased density No gaps between struts 9F delivery system lengths to 120 mm Diameters 12 to 16 mm 8
9 Radial strength testing Standard bench testing method measures crush resistance of expanded stent in Newtons SS Nit stand Nit Novel 9
10 Current status of venous stent development in US Veniti VICI stent Cook Zilver Venous Both have completed enrollment of venous stenting trials of approx 200 patients each Results expected Q1 2018
11 New Data from Clinical Trials: Leverage to improve QOL and classification systems Volcano Video trial QOL data Veniti stent clinical trial Cook venous clinical trial Does symptom improvement depend on severity of disease?
12 Venous stents in use in Europe Vici venous (Veniti) Zilver venous (Cook) Sinus Venous (Optimed) Bard
13 PTS NIVL Veniti VIRTUS trial Image courtesy of Mr. Stephen Black Objective Safety Assess safety & effectiveness in achieving patency of target venous lesion through 12-M post stent placement 30 days Effectivess Primary 12-M Principle Investigators Study Design Patient Population Pivotol Subjects Core Lab Dr. William Marston Dr. Mahmood Razavi Prospective, multicenter, single arm non-randomized, up to 45 sites worldwide 200 subjects with clinically significant chronic non-malignant obstruction of the iliofemoral venous segment first 30 were feasibility. Two Treatment Groups - 43 NIVL subjects and 127 PTS subjects Venography Syntactx, IVUS St. Lukes, DUS - Vascore Image courtesy of Dr. Mahmood Razavi
14 VIRTUS Study: Feasibility Cohort by DUS (Site Reported & Corelab Analysis) Patency Results of Full Cohort (N=30) Primary Patency Secondary Patency 6 M 96±4% 100% 12 M 90±7% 100% Image courtesy of Dr. Ediberto Soto-Cora
15 VIRTUS Trial Feasibility Cohort Safety Endpoint Primary Safety through 30 Days (n=30) n % Composite Major Adverse Events (MAE) Device or procedure-related death 0 0 Device or procedure-related bleeding 0 0 Device or procedure-related vessel injury 0 0 Device or procedure-related DVT (nontarget vessel segment)* Clinically significant PE 0 0 Embolization of stent 0 0
16 Sinus Venous Stent Designed for implantation in the iliac vein at the iliac confluence High radial force, precise placement Angled leading edge to facilitate treatment of MTS without obstructing contralateral iliac
17 Initial results with Sinus-Venous Stent 75 patients treated 35 non-thrombotic MTS 40 post-thrombotic Implantation success 100% Primary patency 92% at 12 months de Wolfe et al, Eur J Vasc Endovasc Surg 2015;50:518-26
18 Variety of outflow obstruction Type II Type IV Type 1 Type III
19 Further development required Venous confluence device
20 Additional needs for Management of ICVO to move forward Venous stent for inguinal ligament area Device for thrombus > 2-3 weeks old Venous Atherectomy device
21 But there really isn t a large market for these devices
22 C-TRACT Study Effort by group steering ATTRACT trial Randomize patients with severe PTS and ICVO to standard care vs intervention Goal to identify whether venous intervention improves clinically relevant QOL outcomes
23 Questions?
REKANALISATION CHRONISCH VENÖSER VERSCHLÜSSE. Michael K. W. Lichtenberg, FESC
REKANALISATION CHRONISCH VENÖSER VERSCHLÜSSE Michael K. W. Lichtenberg, FESC Conflict of Interest - Disclosure Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
More informationClinical results of venous stents. Michael K. W. Lichtenberg MD, FESC
Clinical results of venous stents Michael K. W. Lichtenberg MD, FESC Conflict of Interest - Disclosure Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation
More informationPatency rates and clinical results of the Veniti VICI Stent for treatment of iliac vein lesion Data from the Arnsberg Venous Registry
Patency rates and clinical results of the Veniti VICI Stent for treatment of iliac vein lesion Data from the Arnsberg Venous Registry Michael K. W. Lichtenberg MD, FESC Conflict of Interest - Disclosure
More informationVIRTUS: Trial Design and Primary Endpoint Results
VIRTUS: Trial Design and Primary Endpoint Results Mahmood K. Razavi, MD St. Joseph Cardiac and Vascular Center Orange, CA, USA IMPORTANT INFORMATION: These materials are intended to describe common clinical
More informationVenous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC
Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label
More informationComplex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.
Complex Iliocaval Reconstruction 2017 PNEC. Seattle WA Bill Marston MD Professor, Div of Vascular Surgery University of N. Carolina DISCLOSURES William Marston, MD Consultant/Advisory Board: Veniti, Cardinal
More informationVIRTUS Trial: Pivotal Cohort 12-Month Primary Safety and Efficacy Results of the VICI Venous Stent System
VIRTUS Trial: Pivotal Cohort 12-Month Primary Safety and Efficacy Results of the VICI Venous Stent System Mahmood K. Razavi, MD St. Joseph Cardiac and Vascular Center Orange, CA, USA Disclosure Speaker
More informationFuture Devices of Venous Interventions
Future Devices of Venous Interventions Director of Peripheral Vascular Medicine Department of Shin Kong Wu Ho-Su Memorial Hospital, Taiwan Interventional Cardiologist Tien-Yu Wu MD Disclosure Speaker name:...
More informationChronic deep venous occlusions: Case planning, recanalization and stent technique
Chronic deep venous occlusions: Case planning, recanalization and stent technique Michael K. W. Lichtenberg, FESC German Venous Center Arnsberg, Germany Conflict of Interest - Disclosure Within the past
More informationHow to best approach chronic venous occlusions?
How to best approach chronic venous occlusions? Prof. Nils Kucher Director Venous Thromboembolism Reseach Group University Hospital Bern nilskucher.com Disclosure Speaker name: Nils Kucher X X I have the
More informationA Dedicated Venous Self-expanding Oblique Hybrid Nitinol Stent (Sinus-Obliquus Stent)
A Dedicated Venous Self-expanding Oblique Hybrid Nitinol Stent (Sinus-Obliquus Stent) Anna Stuck, Rolf P. Engelberger, Nils Kucher Division of Angiology Cantonal Hospital Fribourg & Bern University Hospital
More information2017 Florida Vascular Society
Current Management of Venous Leg Ulcers: How to Identify Patients with Correctable Venous Disease and Interventional Procedures to Heal and Prevent Recurrence 2017 Florida Vascular Society Bill Marston
More informationUnderstanding of the importance of venous
The Critical Need for an Iliofemoral Venous Obstruction Classification System An overview of a potential classification system to better identify and treat iliofemoral venous outflow obstruction. BY WILLIAM
More informationThe Conservative and Active Management of Post Thrombotic Syndrome
The Conservative and Active Management of Post Thrombotic Syndrome Stephen Black Consultant Vascular Surgeon Clinical Lead for Venous and Lymphoedema Surgery Guys and St Thomas Hospital London How important
More informationVIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction
VIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction Gerard J O Sullivan, M.D. and Jennifer McCann-Brown,
More informationShould We Be More Aggressive in the Treatment of Acute DVT?
DISCLOSURES Consultant Penumbra, Inc. UCSF Vascular Surgery Symposium April 6, 2017 K. Pallav Kolli, MD Assistant Professor of Clinical Radiology University of California, San Francisco 17 yo male, DVT
More informationChronic Iliocaval Venous Occlusive Disease
none Chronic Iliocaval Venous Occlusive Disease David Rigberg, M.D. Clinical Professor of Surgery Division of Vascular Surgery University of California Los Angeles Chronic Venous Occlusive Disease Chronic
More informationThe evidence for venous interventions is evolving- many patients do actually benefit. Nils Kucher University Hospital Bern Switzerland
The evidence for venous interventions is evolving- many patients do actually benefit Nils Kucher University Hospital Bern Switzerland Disclosure Speaker name: Nils Kucher X X I have the following potential
More informationCase Study of Implantation of a VICI VENOUS STENT - Combined NIVL and PTS Stenting
Case Study of Implantation of a VICI VENOUS STENT - Combined NIVL and PTS Stenting Courtesy of Mr. Stephen Black United kingdom Patient History 25 y/o female 2011: Conservatively treated ilio-femoral DVT
More informationWhat Really Matters to Patient is QOL: Veniti Virtus Venous Feasibility Trial
DISCLOSURES Speaker name: Lowell S. Kabnick, MD, FACS... I have the following potential conflicts of interest: Consultant and shareholder, VENITI, Inc. Consultant to BARD What Really Matters to Patient
More informationOn Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View
On Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View Peter Gloviczki, MD Ying Huang, MD, PhD Division of Vascular and Endovascular Surgery, Mayo
More informationImaging, it s central role in planning and guiding intervention. Prof. Luis Izquierdo. MD, PhD, FEBVS
Imaging, it s central role in planning and guiding intervention Prof. Luis Izquierdo. MD, PhD, FEBVS IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural
More information- Our patients with iliofemoral DVT - Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes
- Our patients with iliofemoral DVT - Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes Michael K. W. Lichtenberg, FESC Conflict of Interest - Disclosure Within
More informationVenous Stents Placed Below the Inguinal Ligament: No Worries
Venous Stents Placed Below the Inguinal Ligament: No Worries Disclosure Speaker name: Lowell S. Kabnick, MD, FACS, FACPh, RPhS... I have the following potential conflicts of interest to report: Consulting:
More informationVERNACULAR Trial & Clinical Experience with the VENOVO Venous Stent
Stephen Black, MD VERNACULAR Trial & Clinical Experience with the VENOVO Venous Stent 1 Speaker Disclaimers The speakers presentation today is on behalf of Bard Peripheral Vascular, Inc. Any discussion
More informationComplex ilio-caval revascularization in chronic venous obstruction with the Venovo Stent. Michael K. W. Lichtenberg MD, FESC
Complex ilio-caval revascularization in chronic venous obstruction with the Venovo Stent Michael K. W. Lichtenberg MD, FESC German Venous Center Arnsberg, Germany Not available for sale or distribution
More informationVenogram Versus Intravascular Ultrasound for Diagnosing and Treating Iliofemoral Vein Obstruction (VIDIO)
Venogram Versus Intravascular Ultrasound for Diagnosing and Treating Iliofemoral Vein Obstruction (VIDIO) Report From a Multicenter, Prospective Study of Iliofemoral Vein Interventions Paul J. Gagne, MD,
More informationPharmaco-mechanical techniques stand alone procedures? Peter Neglén, MD, PhD SP Vascular Center Limassol Cyprus
Pharmaco-mechanical techniques stand alone procedures? Peter Neglén, MD, PhD SP Vascular Center Limassol Cyprus Faculty Disclosure Peter Neglén, M.D., Ph.D Stockholder/Founder of Veniti, Inc. Member, Medical
More informationWhich Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA
Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA Brian DeRubertis, MD, FACS Associate Professor of Surgery UCLA Division
More informationInterventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
More informationVENOVO Venous Stent Update on the Vernacular Trial
VENOVO Venous Stent Update on the Vernacular Trial Dr. Sunder Narasimhan, MBBS, MS Senior Consultant Vascular and Endovascular Surgeon Apollo Hospital, Bangalore, India VENOVO is a registered trademark
More informationImproved clinical outcomes Evidence on venous thrombectomy followed by stenting
Improved clinical outcomes Evidence on venous thrombectomy followed by stenting Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany Venous Centre Arnsberg, Germany Disclosure Speaker
More informationWhen Outcomes Matter, Design Matters
to receive our latest news and key activities. Cordis S.M.A.R.T. Self-Expanding Nitinol Lower Extremity Solutions When Outcomes Matter, Design Matters For superficial femoral artery (SFA) and iliac lesions.
More informationTechniques for thrombus removal in acute DVT Benefits of an Endovascular Approach for Rapid Flow Restoration in DVT
Techniques for thrombus removal in acute DVT Benefits of an Endovascular Approach for Rapid Flow Restoration in DVT Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany Disclosure Speaker
More informationIntervention for Deep Venous Thrombosis and Pulmonary Embolus
Intervention for Deep Venous Thrombosis and Pulmonary Embolus Michael R. Jaff, DO Paul and Phyllis Fireman Endowed Chair in Vascular Medicine Massachusetts General Hospital Professor of Medicine Harvard
More informationComplications of endovascular treatment of May-Thurner syndrome George Geroulakos
Complications of endovascular treatment of May-Thurner syndrome George Geroulakos Professor of Vascular Surgery, National and Kapodistrian University of Athens Director, Department of Vascular Surgery,
More informationImage-Guided Approach to Treatment of Patients with Nonthrombotic
Image-Guided Approach to Treatment of Patients with Nonthrombotic May Thurner Syndrome Brian DeRubertis, MD, FACS Associate Professor of Surgery Division of Vascular Surgery UCLA School of Medicine Los
More informationVenous interventions in DVT
Venous interventions in DVT Sriram Narayanan Chief of Vascular and Endovascular Surgery, Tan Tock Seng Hospital A/Prof of Surgery, National University of Singapore ANTI-COAGULATION LMWH Warfarin x 6m Acute
More informationOvation. Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic
Ovation Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
More informationThe Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations
The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations Joseph V. Lombardi, MD Professor & Chief, Division of Vascular & Endovascular Surgery Department of Surgery,
More informationEarly Clinical Results with the Valiant Mona LSA Branch Stent-Graft
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft Frank R. Arko III, MD Professor of Cardiovascular Surgery Director, Endovascular Surgery Co-Director, Aortic Institute Carolinas Medical
More informationStarting with deep venous treatment
Starting with deep venous treatment Carsten Arnoldussen, MD Interventional Radiologist Maastricht University Medical Centre, Maastricht VieCuri Medical Centre, Venlo The Netherlands Background Maastricht
More informationAccess More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
More informationChristian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide
2-Year Results Of The Tack Optimized Balloon Angioplasty (TOBA) Trial For Fem- Pop Lesions Demonstrates Safety and Efficacy Of The Tack Endovascular System In Repairing Focal Post-PTA Dissections Christian
More informationAccurate Vessel Sizing Drives Clinical Results. IVUS In the Periphery
Accurate Vessel Sizing Drives Clinical Results IVUS In the Periphery Discussion Iida O, et. al. Study Efficacy of Intravascular Ultrasound in Femoropopliteal Stenting for Peripheral Artery Disease With
More informationProven Performance Through Innovative Design *
Proven Performance Through Innovative Design * Deliver Our Next Generation AV Covered Stent Results The COVERA Vascular Covered Stent builds upon proven technologies from the category leader in AV Access.
More informationPulsar stent technology
Pulsar stent technology Michael K. W. Lichtenberg Vascular Center Arnsberg Disclosures Speaker name: Michael Lichtenberg... I have the following potential conflicts of interest to report: X Consulting
More informationThe role of ultrasound duplex in endovenous procedures
The role of ultrasound duplex in endovenous procedures Neophytos A. Zambas MD, PhD Vascular Surgeon Polyclinic Ygia, Limassol, Cyprus ΚΕΑΕΧ ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΑΓΓΕΙΑΚΗΣ ΚΑΙ ΕΝΔΑΓΓΕΙΑΚΗΣ ΧΕΙΡΟΥΡΓΙΚΗΣ Pre
More informationAnticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis
Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis Tim Sebastian, M.D. University Hospital Zurich Clinic for Angiology Disclosure Speaker name: Tim Sebastian I
More informationCurrent Best Practices, Trial Experiences, and Device Designs
ROUNDTABLE DISCUSSION VENOUS Venous Stenting Perspectives: Current Best Practices, Trial Experiences, and Device Designs WITH STEVEN D. ABRAMOWITZ, MD; STEPHEN A. BLACK, MD, FRCS(Ed), FEBVS; MICHAEL D.
More informationAspirex for Upper and Lower Extremity DVT
Aspirex for Upper and Lower Extremity DVT Steven Kum MD Vascular & Endovascular Surgeon Director of Vascular Service Changi General Hospital Singapore Disclosure Speaker name:... I have the following potential
More informationTreatment of Chronic DVT with EKOS: Reproducing ACCESS PTS Data in Every Day Clinical Practice
Treatment of Chronic DVT with EKOS: Reproducing ACCESS PTS Data in Every Day Clinical Practice Mert Dumantepe, MD Acibadem Altunizade Hospital, Istanbul, Turkey Department of Cardiovascular Surgery Disclosure
More informationUpdate on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria
Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee Marianne Brodmann, MD Medical University Graz Graz, Austria Critical Limb Ischemia Infrapopliteal arterial disease is a leading source
More informationIliofemoral DVT: Miminizing Post-Thrombotic Syndrome
Iliofemoral DVT: Miminizing Post-Thrombotic Syndrome Catherine K. Chang, MD FACS Vascular Surgery San Diego Southern California Permanente Medical Group Acute Deep Venous Thrombosis Incidence & Outcomes
More informationDisclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard?
Disclosures Boston Scientific, Medical Advisory Board Endologix Corp., Consultant and trainer, AFX Aorto-Iliac Disease: Bare Metal, Covered or Stent Grafts How I Decide John S. Lane III MD, FACS Professor
More informationEmerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease
FEATURED TECHNOLOGY THE CLOTTRIEVER AND FLOWTRIEVER SYSTEMS Emerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease The ClotTriever Outcomes (CLOUT) registry principal
More informationDurability of The Endurant Stent-Graft through 5 Years
Durability of The Endurant Stent-Graft through 5 Years Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh School
More informationThe Ventana Off-the-Shelf Graft for Pararenal AAA. Andrew Holden Associate Professor of Radiology Auckland Hospital
The Ventana Off-the-Shelf Graft for Pararenal AAA Andrew Holden Associate Professor of Radiology Auckland Hospital Disclosures Andrew Holden, MBChB, FRANZCR Investigator in Nellix and Ventana Trials Clinical
More informationEndoVascular Aneurysm Sealing (EVAS) with Nellix
1 2 EndoVascular Aneurysm Sealing (EVAS) with Nellix Designed to seal entire aneurysm with contained biostable polymer Non-modular design with complete fixation Expands endovascular patient eligibility
More informationThe initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction
The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction Mahmood Razavi, MD, a William Marston, MD, b Stephen Black,
More informationWhen to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs LINC ASIA 18
When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs JEAN-PAUL P.M. DE VRIES, DIRECTOR OF VASCULAR SURGERY ST.ANTONIUS HOSPITAL NIEUWEGEIN, THE NETHERLANDS. LINC ASIA-PACIFIC HongKong,
More informationGORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts
More informationNew Data to Shape the Era of Drug Elution in Peripheral Interventions
New Data to Shape the Era of Drug Elution in Peripheral Interventions William A. Gray MD Director of Endovascular Services Columbia University Medical Center New York Lower Extremity Endovascular - Interventions
More informationEVAS How does this Impact EVAR Therapy
EVAS How does this Impact EVAR Therapy John S. Lane III, MD, FACS Professor and Acting Chief of Vascular Surgery University of California, San Diego PNEC, 2017 Endologix products and associated components
More informationCopy Here. The Easy One.. What is the Role of Thrombus Removal in Acute Proximal DVT after ATTRACT? Deep Venous Thrombosis Spectrum
What is the Role of Thrombus Removal in Acute Proximal DVT after ATTRACT? Mitchell J. Silver DO FACC FSVM RPVI Director, Center for Critical Limb Care Riverside Methodist Hospital Ohio Health Heart and
More informationTalent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
More informationTHERE IS NO ROLE FOR SURGICAL THERAPY FOR DVT
THERE IS NO ROLE FOR SURGICAL THERAPY FOR DVT Tara D. Balint, MD FACS Sentara RMH Thursday, June 14, 2018 1 Objectives of treatment for DVT Prevent death from PE Prevent recurrent VTE Prevent post-thrombotic
More informationImproved clinical outcomes Evidence on venous mechanical thrombectomy followed by stenting
Improved clinical outcomes Evidence on venous mechanical thrombectomy followed by stenting Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany German Venous Centre Arnsberg, Germany Disclosure
More informationStraub Endovascular System &
Straub Endovascular System & S t r a u b E n d o v a s c u l a r To o l s Straub Endovascular System Effective debulking in occluded arteries and veins Effective debulking in many indications Rotarex
More informationPercutaneous Mechanical Thrombectomy for Acute Iliofemoral DVT with the Aspirex Catheter: The Dijon Experience
JFICV 2018, Beaune Percutaneous Mechanical Thrombectomy for Acute Iliofemoral DVT with the Aspirex Catheter: The Dijon Experience Prof. Romaric LOFFROY, MD, PhD, FCIRSE Chief, Department of Vascular and
More informationExpanding to every demand: The GORE VIABAHN VBX Stent Graft
Expanding to every demand: The GORE VIABAHN VBX Stent Graft GORE, VIABAHN, and designs are trademarks of W. L. Gore & Associates. 2017 W. L. Gore & Associates, Inc. Program Faculty Martin Austermann, MD
More informationFrom 1996 to 1999, a total of 1,193 patients with
THE ANEURX CLINICAL TRIAL AT 8 YEARS Lessons learned following the US AneuRx clinical trial from 1996 to 2004. BY CHRISTOPHER K. ZARINS, MD From 1996 to 1999, a total of 1,193 patients with infrarenal
More informationExtreme SFA Lesions: DETOUR I 12- Month Results in Lesions >30cm. Sean Lyden, MD Chairman Vascular Surgery Cleveland Clinic Cleveland, Ohio
Extreme SFA Lesions: DETOUR I 12- Month Results in Lesions >30cm Sean Lyden, MD Chairman Vascular Surgery Cleveland Clinic Cleveland, Ohio Extreme SFA Lesions: DETOUR I 12-Month Results in Lesions >30cm
More informationRegardless of whether you are a vascular surgeon,
C A S E R E P O R T The Versatility of the GORE VIABAHN Endoprosthesis Several case reports highlighting its unique design and why it is a valuable tool for the interventionist. BY PETER WAYNE, MD Regardless
More informationBC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8
BC Vascular Day Contents Abdominal Aortic Aneurysm 2 3 November 3, 2018 Peripheral Arterial Disease 4 6 Deep Venous Thrombosis 7 8 Abdominal Aortic Aneurysm Conservative Management Risk factor modification
More informationDrug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort
Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort a.o. Univ. Prof. Dr. Marianne Brodmann Medical University of Graz Graz,
More informationEKOS. Interventional Vascular 3 February, Imagine where we can go.
EKOS Interventional Vascular 3 February, 2015 Imagine where we can go. Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other
More informationRandomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein
Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein Raghu Kolluri, MD, Director Vascular Medicine OhioHealth Riverside Methodist Hospital
More informationNot all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Case 1:
12/16/2015 Not all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Constantino S.Peña, FSIR, FSCCT, FAHA Interventional Radiologist Medical Director, Vascular Imaging Miami
More informationMaximize Control. Minimize Migration.
Maximize Control. Minimize Migration. New SHORT WIRE Delivery System SHORT W IRE BILIARY ENDOPROSTHESIS Improved treatment of biliary strictures The self-expanding, fully covered metal stent is intended
More informationAggressive endovascular management of ilio-femoral DVT. thrombotic syndrome. is the key in preventing post
CACVS 2017 Aggressive endovascular management of ilio-femoral DVT is the key in preventing post thrombotic syndrome ALI AMIN MD, FACS,FACC, RVT CHIEF OF ENDOVASCULAR INTERVENTIONS READING HEALTH SYSTEM
More informationEvidence for endovascular therapy of iliofemoral DVT: CAVENT, ATTRACT, CAVA and more to come
Evidence for endovascular therapy of iliofemoral DVT: CAVENT, ATTRACT, CAVA and more to come Stephen Black Consultant Vascular Surgeon Reader in Venous Surgery Or rephrased To lyse or not to lyse: that
More informationKoen Keirse, MD RZ Tienen, Belgium
Clinical Benefits of the Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection from the ENTRAP Study Koen Keirse, MD RZ Tienen, Belgium Disclosure Speaker name: Koen Keirse...
More informationPreliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study
Preliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study Mark A Farber, MD Professor of Surgery and Radiology Director, UNC Aortic Network University of North
More informationOstial Stents and Distal Embolic Protection During Renal Stenting
Ostial Stents and Distal Embolic Protection During Renal Stenting John R. Laird, MD Professor of Medicine Director of the Vascular Center UC Davis Medical Center Limitations of Current Techniques of Renal
More informationTreatment Strategies for Long Lesions of greater than 20 cm
Treatment Strategies for Long Lesions of greater than 20 cm Donald L. Jacobs, MD C. Rollins Hanlon Professor and Chair Chair of the Department of Surgery Saint Louis University Disclosure Speaker name:
More informationa physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers
The study a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers Conflict of interest have the following potential conflicts of interest to report: Consulting
More information14F OD Ovation Abdominal Stent Graft System
14F OD Ovation Abdominal Stent Graft System 2 Year Results from the European Study Dierk Scheinert, MD Center for Vascular Medicine Angiology and Vascular Surgery Park Hospital Leipzig, Germany Disclosure
More informationComplete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction. Erin H. Murphy, MD Rane Center
Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction Erin H. Murphy, MD Rane Center Disclosure Speaker name: Erin H. Murphy... I have the following potential conflicts
More informationUltrasound-assisted catheter-directed thrombolysis: Does it really work? The BERNUTIFUL trial
Ultrasound-assisted catheter-directed thrombolysis: Does it really work? The BERNUTIFUL trial Rolf P. Engelberger Division of Angiology CHUV, Lausanne & Inselspital, Bern Switzerland Disclosure Speaker
More informationTreatment options of late failures of EVAS. Michel Reijnen Rijnstate Arnhem The Netherlands
Treatment options of late failures of EVAS Michel Reijnen Rijnstate Arnhem The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts of interest to report: Consulting
More informationMy personal experience with INCRAFT in standard and challenging cases
My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,
More informationVariation of stent placement for distal abdominal aorta Lesion
Variation of stent placement for distal abdominal aorta Lesion Tatsuki Doijiri M.D Department of Cardiology Yamato-Seiwa Hospital Kanagawa Japan Disclosure Speaker name: Tatsuki Doijiri... I have the following
More informationWilliam A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA
William A. Gray MD System Chief of Cardiovascular Services, President, Wynnewood, PA USA What are the possible causes of stroke in CAS? Operator error Technique (balloon sizing, wire misadventure, EPD
More informationSafety and Feasibility of Intravascular Lithotripsy for Treatment of Common Femoral Artery Stenoses
Safety and Feasibility of Intravascular Lithotripsy for Treatment of Common Femoral Artery Stenoses Pr Marianne Brodmann, MD Univ. Klinik für Innere Medizin Medizinische Universtität Graz 1 Disclosure
More informationRight Choice for Right Angles
Right Choice for Right Angles The Anatomy of Technology Aorfix gives you technology that conforms to patient anatomy, optimising both procedure and post-operative performance. Fishmouth for optimum neck
More informationSurgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine
Surgical approach for DVT Seung-Kee Min Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine Treatment Options for Venous Thrombosis Unfractionated heparin &
More informationRESULTS OF VIABAHN IN AORTO ILIAC OCCLUSION
RESULTS OF VIABAHN IN AORTO ILIAC OCCLUSION JORGE FERNÁNDEZ NOYA ANGIOLOGY AND VASCULAR SURGERY DEPARTMENT UNIVERSITY CLINICAL HOSPITAL SANTIAGO DE COMPOSTELA ALTERNATIVAS ENDOVASCULAR TERAPÉUTICAS TREATMENT
More informationPRISM Trial. Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery
PRISM Trial Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery George L. Adams, MD, MHS, FACC, FSCAI Clinical Associate Professor
More informationIVUS is strongly recommanded before treating a venous femoro-iliac obstruction CONS. F Thony CHU Grenoble
IVUS is strongly recommanded before treating a venous femoro-iliac obstruction CONS F Thony CHU Grenoble Disclosure Speaker name: Frédéric THONY I do not have any potential conflict of interest Introduction
More information